cAMP-Phosphodiesterase 8 family

Cyclic Nucleotide Phosphodiesterases in Health and Disease

Volumn , Issue , 2006, Pages 205-219

  Vasta, Valeria ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950255619     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (72)

1. Fisher, D.A., et al. 1998. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 246 (3): 570-7.
2. Soderling, S.H., S.J. Bayuga, and J.A. Beavo. 1998. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci USA 95 (15): 8991-6.
3. Soderling, S.H., and J.A. Beavo. 2000. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions. Curr Opin Cell Biol 12 (2): 174-9.
4. Wang, P., et al. 2001. Human phosphodiesterase 8A splice variants: Cloning, gene organization, and tissue distribution. Gene 280 (1-2): 183-94.
5. Hayashi, M., et al. 2002. Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene. Biochem Biophys Res Commun 297 (5): 1253-8.
6. Glavas, N.A., et al. 2001. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc Natl Acad Sci USA 98 (11): 6319-24.
7. Yuasa, K., et al. 2005. PfPDE1, a novel cGMP-specific phosphodiesterase, from the human malaria parasite Plasmodium falciparum. Biochem J 392 (Pt 1): 221-9.
8. Hayashi, M., et al. 1998. Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 250 (3): 751-6.
9. Kobayashi, T., et al. 2003. Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: Unique expression of PDE8B in rat brain. Gene 319: 21-31.
10. Day, J.P., et al. 2005. Cyclic nucleotide phosphodiesterases in Drosophila melanogaster. Biochem J 388 (Pt 1): 333-42.
11. Gamanuma, M., et al. 2003. Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans. Cell Signal 15 (6): 565-74.
12. Fisher, D.A., et al. 1998. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 273 (25): 15559-64.
13. Rascon, A., et al. 2002. Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei. Proc Natl Acad Sci USA 99 (7): 4714-9.
14. Zoraghi, R., and T. Seebeck. 2002. The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma brucei. Proc Natl Acad Sci USA 99 (7): 4343-8.
15. Lavan, B.E., T. Lakey, and M.D. Houslay. 1989. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochem Pharmacol 38 (22): 4123-36.
16. Card, G.L., et al. 2004. Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure (Camb) 12 (12): 2233-47.
17. Liu, S., et al. 2005. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. J Pharmacol Exp Ther 314 (2): 846-54.
18. Huai, Q., et al. 2004. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Proc Natl Acad Sci USA 101 (26): 9624-9.
19. Blumenthal, T. 1998. Gene clusters and polycistronic transcription in eukaryotes. Bioessays 20 (6): 480-7.
20. Lejeune, F., and L.E. Maquat. 2005. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell Biol 17 (3): 309-15.
21. Lewis, B.P., R.E. Green, and S.E. Brenner. 2003. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 100 (1): 189-92.
22. Lareau, L.F., et al. 2004. The evolving roles of alternative splicing. Curr Opin Struct Biol 14 (3): 273-82.
23. Stamm, S., et al. 2005. Function of alternative splicing. Gene 344: 1-20.
24. Vicini, E., and M. Conti. 1997. Characterization of an intronic promoter of a cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol Endocrinol 11 (7): 839-50.
25. Fujishige, K., et al. 2000. The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains. Eur J Biochem 267 (19): 5943-51.
26. Torras-Llort, M. and F. Azorin. 2003. Functional characterization of the human phosphodiesterase 7A1 promoter. Biochem J 373 (Pt 3): 835-43.
27. Liu, H., et al. 2005. Identification of promoter elements in 5'-flanking region of murine cyclic nucleotide phosphodiesterase 3B gene. Methods Mol Biol 307: 109-24.
28. Marshall, E. 2004. Getting the noise out of gene arrays. Science 306 (5696): 630-1.
29. Sherlock, G. 2005. Of fish and chips. Nat Methods 2 (5): 329-30.
30. Shima, J.E., et al. 2004. The murine testicular transcriptome: Characterizing gene expression in the testis during the progression of spermatogenesis. Biol Reprod 71 (1): 319-30.
31. Robinson, V.L., D.R. Buckler, and A.M. Stock. 2000. A tale of two components: a novel kinase and a regulatory switch. Nat Struct Biol 7 (8): 626-33.
32. Elsen, S., et al. 2004. RegB/RegA, a highly conserved redox-responding global two-component regulatory system. Microbiol Mol Biol Rev 68 (2): 263-79.
33. Thomason, P.A., et al. 1999. The RdeA-RegA system, a eukaryotic phospho-relay controling cAMP breakdown. J Biol Chem 274 (39): 27379-84.
34. Ott, A., et al. 2000. Osmotic stress response in Dictyostelium is mediated by cAMP. Embo J 19 (21): 5782-92.
35. Steeg, P.S., et al. 2003. Histidine kinases and histidine phosphorylated proteins in mammalian cell biology, signal transduction and cancer Cancer Lett 190 (1): 1-12.
36. Besant, P.G., E. Tan, and P.V. Attwood. 2003. Mammalian protein histidine kinases. Int J Biochem Cell Biol 35 (3): 297-309.
37. Ponting, C.P., and L. Aravind. 1997. PAS: A multifunctional domain family comes to light. Curr Biol 7 (11): R674-7.
38. Taylor, B.L., and I.B. Zhulin. 1999. PAS domains: Internal sensors of oxygen, redox potential, and light. Microbiol Mol Biol Rev 63 (2): 479-506.
39. Vreede, J., et al. 2003. PAS domains. Common structure and common flexibility. J Biol Chem 278 (20): 18434-9.
40. Romling, U., M. Gomelsky, and M.Y. Galperin. 2005. C-di-GMP: The dawning of a novel bacterial signalling system. Mol Microbiol 57 (3): 629-39.
41. Sasakura, Y., et al. 2002. Characterization of a direct oxygen sensor heme protein from Escherichia coli. Effects of the heme redox states and mutations at the heme-binding site on catalysis and structure. J Biol Chem 277 (26): 23821-7.
42. Tal, R., et al. 1998. Three cdg operons control cellular turnover of cyclic di-GMP in Acetobacter xylinum: Genetic organization and occurrence of conserved domains in isoenzymes. J Bacteriol 180(17): 4416-25.
43. Delgado-Nixon, V.M., G. Gonzalez, and M.A. Gilles-Gonzalez. 2000. Dos, a heme-binding PAS protein from Escherichia coli, is a direct oxygen sensor. Biochemistry 39 (10): 2685-91.
44. Kurokawa, H., et al. 2004. A redox-controlled molecular switch revealed by the crystal structure of a bacterial heme PAS sensor. J Biol Chem 279 (19): 20186-93.
45. Aravind, L., V. Anantharaman, and L.M. Iyer. 2003. Evolutionary connections between bacterial and eukaryotic signaling systems: A genomic perspective. Curr Opin Microbiol 6 (5): 490-7.
46. Tomita, T., et al. 2002. A comparative resonance Raman analysis of heme-binding PAS domains: Heme iron coordination structures of the BjFixL, AxPDEA1, EcDos, and MtDos proteins. Biochemistry 41 (15): 4819-26.
47. Wu, P., and P. Wang. 2004. Per-Arnt-Sim domain-dependent association of cAMP-phosphodiesterase 8A1 with IkappaB proteins. Proc Natl Acad Sci USA 101 (51): 17634-9.
48. Rutter, J. 2002. Essay: Amersham biosciences and science prize. PAS domains and metabolic status signaling. Science 298 (5598): 1567-8.
49. Amezcua, C.A., et al. 2002. Structure and interactions of PAS kinase N-terminal PAS domain: Model for intramolecular kinase regulation. Structure (Camb) 10 (10): 1349-61.
50. Baxendale, R.W., and L.R. Fraser. 2005. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation. Mol Reprod Dev 71 (4): 495-508.
51. Esposito, G., et al. 2004. Mice deficient for soluble adenylyl cyclase are infertile because of a severe sperm-motility defect. Proc Natl Acad Sci USA 101 (9): 2993-8.
52. Nolan, M.A., et al. 2004. Sperm-specific protein kinase A catalytic subunit Calpha2 orchestrates cAMP signaling for male fertility. Proc Natl Acad Sci USA 101 (37): 13483-8.
53. Perez-Torres, S., et al. 2003. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol 182 (2): 322-34.
54. Vang, T., et al. 2003. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling. J Biol Chem 278 (20): 17597-600.
55. Ahlstrom, M., et al. 2005. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation. Cell Mol Biol Lett 10 (2): 305-19.
56. Wakabayashi, S., et al. 2002. Involvement of phosphodiesterase isozymes in osteoblastic differentiation. J Bone Miner Res 17 (2): 249-56.
57. Qin, L., L.J. Raggatt, and N.C. Partridge. 2004. Parathyroid hormone: A double-edged sword for bone metabolism. Trends Endocrinol Metab 15 (2): 60-5.
58. Rizzoli, R., V. von Tscharner, and H. Fleisch. 1986. Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells. Biochem J 237 (2): 447-54.
59. Wong, M.M., et al. 1990. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res 5 (8): 803-13.
60. Dremier, S., et al. 2002. The role of cyclic AMP and its effect on protein kinase A in the mitogenic action of thyrotropin on the thyroid cell. Ann NY Acad Sci 968: 106-21.
61. Spiegel, A.M. 1996. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 81 (7): 2434-42.
62. Persani, L., et al. 2000. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J Clin Endocrinol Metab 85 (8): 2872-8.
63. Persani, L., et al. 2001. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: Effect of Gs(alpha) mutations. J Clin Endocrinol Metab 86 (8): 3795-800.
64. Wattel, S., et al. 2005. Gene expression in thyroid autonomous adenomas provides insight into their physiopathology. Oncogene 24 (46): 6902-16.
65. Bartsch, O., B. Bartlick, and R. Ivell. 2004. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 89 (1): 324-34.
66. Wheeler, D.B., et al. 2004. RNAi living-cell microarrays for loss-of-function screens in Drosophila melanogaster cells. Nat Methods 1 (2): 127-32.
67. O'Rourke, S.M., and B. Bowerman. 2005. Genomics: Frontiers of gene function. Nature 434 (7032): 444-5.
68. Park, J.Y., et al. 2003. Phosphodiesterase regulation is critical for the differentiation and pattern of gene expression in granulosa cells of the ovarian follicle. Mol Endocrinol 17 (6): 1117-30.
69. Fraser, A.G., et al. 2000. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408 (6810): 325-30.
70. Sonnichsen, B., et al. 2005. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 434 (7032): 462-9.
71. Bateman, A., et al. 2004. The Pfam protein families database. Nucleic Acids Res 32 (Database issue): D138-41.
72. Xu, R.X., et al. 2000. Atomic structure of PDE4: Insights into phosphodiesterase mechanism and specificity. Science 288 (5472): 1822-5.